Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.
about
Sphingolipids in spinal cord injuryAstrocyte heterogeneity across the brain and spinal cord occurs developmentally, in adulthood and in response to demyelination.Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.Poly(I:C) promotes TNFα/TNFR1-dependent oligodendrocyte death in mixed glial cultures.Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.Activation of oligodendroglial Stat3 is required for efficient remyelination.Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.A biological perspective of CSF lipids as surrogate markers for cognitive status in HIVSignaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis.Quantitative metabolic profiling of lipid mediators.Reduced thalamic volume in preterm infants is associated with abnormal white matter metabolism independent of injury.Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate.Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system.Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit.Modeling the encephalopathy of prematurity in animals: the important role of translational research.Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelinationFunctional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics.Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism.Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.
P2860
Q27026103-5696F198-E3D4-4B62-96F2-2F196E12D330Q33897709-84F9ABEC-3B14-415A-92CD-9DD95F401D57Q33902931-5C1042FE-23DE-415C-B412-C9AAB2327687Q35184144-89771CC6-1759-4D75-85DC-4DB39A422EF5Q35753667-21BC1C6C-C06D-49C6-A480-91BF5E91BD1CQ36960355-E7701B1D-9354-4B43-88CF-9B38ED49705AQ37099695-7C8F40BE-D77D-4B34-BE0B-A1597FD57DC1Q37129632-C5CA9768-47BF-49D8-9090-C28870B53099Q37389500-30EE137A-EDA6-42BB-B4BC-C48813E2C3C9Q37541514-3521B718-55A8-4AE9-9D4F-FC89F770F904Q37997376-D791FF02-DE12-4EA6-8DCD-B2F7859B8E4DQ38119472-5CB9CE95-971E-4B43-800C-9175104D5BFCQ38416341-3BD781F3-CC0C-4642-8120-3F6F2BEF076AQ38734351-0C8767A4-FC85-4817-B995-1DD591BE3C1FQ38774697-FA5EFD9A-A227-4442-B512-FC23DBE20391Q39034690-C2AB9A89-FEE4-4DCD-9A85-24815ECBAF27Q39106107-37D167A1-F6C1-4DD0-B07E-C2BB456A65E8Q41453152-3DDD8BD6-C291-4CE2-AE23-7ED4882D883CQ42183221-6A4E5317-B70D-4C63-806E-2B8CD7CF7DA3Q42221029-1C4C3219-B330-4128-B0B0-CCC11AF7F2ADQ47343678-365E8C02-EAAE-4356-9C49-F827C24D2FB3Q47848197-6F5D1A7C-C5AB-4E1C-B611-6B47E06AAA2CQ48435795-AAA914D6-54C1-4AAF-9281-E5025B9DB1DAQ50050920-B91DB73C-AA7A-4874-8C08-3A910826436DQ50592328-32B65F2C-274E-4AED-9F13-8ACEA6273EEBQ52691981-E5F471EB-A41E-4806-B6DB-ED80C3AF08BD
P2860
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.
@ast
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.
@en
type
label
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.
@ast
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.
@en
prefLabel
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.
@ast
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.
@en
P2093
P2860
P1433
P1476
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury
@en
P2093
Andrew J Steelman
Hannah C Kinney
Yumin Zhang
P2860
P356
10.1111/J.1750-3639.2011.00501.X
P50
P577
2011-08-16T00:00:00Z